The Technology Behind Ingestible Insulin

Oct. 22 (Bloomberg) -- Oramed CEO Nadav Kidron discusses the technology behind ingestible insulin on Bloomberg Television's "Money Moves." (Source: Bloomberg)
Meet the CEO Who Cut His $1M Salary to $70K
56:28 - Gravity Payments CEO Dan Price explains why he cut his $1 million salary to $70,000. He speaks with Bloomberg's Pimm Fox on "Taking Stock." (Source: Bloomberg)
  • Equity Valuations Lofty, Earnings Lousy: Morganlander
  • `Time Is of the Essence' for Greece to Reach Deal: Lew
  • A Penthouse Perspective on NYC Real Estate